TRIZAL study: switching from successful HAART to TrizivirTM (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1468-1293.2003.00139.x/fullpdf
Reference19 articles.
1. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
2. HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study
3. Potential factors affecting adherence with HIV therapy
4. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection
5. Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nucleoside inhibitors of reverse transcriptase as a basis for the first line anti-retroviral therapy of HIV infection;Clinical Medicine (Russian Journal);2017-08-04
2. An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy;PLOS ONE;2016-05-19
3. Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration;BMC Medicine;2016-03-31
4. Abacavir;Meyler's Side Effects of Drugs;2016
5. A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study;HIV Medicine;2014-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3